Myriad Genetics (MYGN) Earnings Date, Estimates & Call Transcripts → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free MYGN Stock Alerts $25.47 +0.22 (+0.87%) (As of 05/10/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 7) -$0.01 Beat By $0.09 Consensus EPS (May. 7) -$0.10 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Myriad Genetics Earnings AlertsEnter your email address below to receive the latest news and earnings results for MYGN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMYGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MYGN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. For one main reason.In answer to this issue, we have released a Special Report to the public. Myriad Genetics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242($0.15)($0.13)($0.14) Q2 20242($0.07)($0.06)($0.07) Q3 20242($0.07)($0.06)($0.07) Q4 20242($0.04)($0.02)($0.03) FY 20248($0.33)($0.27) ($0.30)MYGN Earnings Date and InformationMyriad Genetics last posted its quarterly earnings results on May 7th, 2024. The reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.10) by $0.09. The company earned $202.20 million during the quarter, compared to analysts' expectations of $193.51 million. Its revenue for the quarter was up 11.6% on a year-over-year basis. Myriad Genetics has generated ($2.82) earnings per share over the last year (($2.82) diluted earnings per share). Earnings for Myriad Genetics are expected to grow in the coming year, from ($0.36) to ($0.09) per share. Myriad Genetics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Myriad Genetics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024Estimated)------- 5/7/2024Q1 2024($0.10)($0.01)+$0.09$0.01$193.51 million$202.20 million 2/27/2024Q4 2023$0.01$0.04+$0.03$0.22$194.80 million$196.60 million 11/6/2023Q3 2023($0.08)($0.03)+$0.05$0.41$179.23 million$191.90 million 8/3/2023Q2 2023($0.08)($0.08)-$1.00$187.16 million$183.50 million 5/3/2023Q1 2023($0.19)($0.21)($0.02)$0.11$171.56 million$181.20 million 2/28/2023Q4 2022($0.27)($0.20)+$0.07$0.12$169.16 million$177.80 million Get the Latest News and Ratings for MYGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Myriad Genetics and its competitors with MarketBeat's FREE daily newsletter. 11/1/2022Q3 2022($0.15)($0.27)($0.12)($0.11)$172.12 million$156.40 million8/4/2022Q2 2022($0.09)($0.06)+$0.03$0.06$170.05 million$179.30 million 5/5/2022Q1 2022($0.15)($0.14)+$0.01($0.02)$156.09 million$164.90 million 2/24/2022Q4 2021($0.15)($0.11)+$0.04($0.12)$162.21 million$160.80 million 11/2/2021Q3 2021($0.02)($0.02)-($0.54)$164.35 million$167.30 million 8/3/2021Q2 2021($0.09)$0.12+$0.21$0.12$163.09 million$189.40 million Myriad Genetics Earnings - Frequently Asked Questions When is Myriad Genetics's earnings date? Myriad Genetics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on MYGN's earnings history. Did Myriad Genetics beat their earnings estimates last quarter? In the previous quarter, Myriad Genetics (NASDAQ:MYGN) reported ($0.01) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.10) by $0.09. Learn more on analysts' earnings estimate vs. MYGN's actual earnings. How can I listen to Myriad Genetics's earnings conference call? The conference call for Myriad Genetics's latest earnings report can be listened to online. Listen to Conference Call How can I read Myriad Genetics's conference call transcript? The conference call transcript for Myriad Genetics's latest earnings report can be read online. Read Transcript How can I view Myriad Genetics's earnings report? Myriad Genetics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Myriad Genetics generate each year? Myriad Genetics (NASDAQ:MYGN) has a recorded annual revenue of $753.20 million. How much profit does Myriad Genetics generate each year? Myriad Genetics (NASDAQ:MYGN) has a recorded net income of -$263.30 million. MYGN has generated -$2.82 earnings per share over the last four quarters. What is Myriad Genetics's EPS forecast for next year? Myriad Genetics's earnings are expected to grow from ($0.36) per share to ($0.09) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Celldex Therapeutics Earnings Date Intellia Therapeutics Earnings Date Neogen Earnings Date QuidelOrtho Earnings Date Lantheus Earnings Date Catalyst Pharmaceuticals Earnings Date NeoGenomics Earnings Date Schrödinger Earnings Date Harmony Biosciences Earnings Date Beam Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:MYGN) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsCollapse of the Petrodollar Colonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myriad Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.